+91-8455-699999
Corporate Brochure
|
Fosun Pharma
Home
(current)
About Us
Our Capabilities
API Facilities
Formulation Facilities
R&D
Our Business
Business Model
India Business
Therapeutic Coverage
Investors
FINANCIALS
SUBSIDIARY FINANCIALS
ANNUAL REPORTS
ANNUAL RETURN
PRESENTATIONS
SHAREHOLDER'S INFORMATION
STOCK EXCHANGE ANNOUNCEMENTS
CORPORATE GOVERNANCE
DISCLOSURES UNDER REGULATION 46 SEBI(LODR)
INVESTORS CONTACT
Resources
NEWS
CSR
Contact Us
Search
Home
About Us
Our Capabilities
API Facilities
Formulation Facilities
R&D
OUR BUSINESS
Business Model
India Business
Therapeutic Coverage
INVESTORS
FINANCIALS
SUBSIDIARY FINANCIALS
ANNUAL REPORTS
ANNUAL RETURN
PRESENTATIONS
SHAREHOLDER'S INFORMATION
STOCK EXCHANGE ANNOUNCEMENTS
CORPORATE GOVERNANCE
DISCLOSURES UNDER REGULATION 46 SEBI(LODR)
INVESTORS CONTACT
Resources
NEWS
CSR
Contact Us
Home
Investors
Subsidiary Financials
Gland Pharma Investors Subsidiary Financial Overview
FY24
FY23
FY22
FY21
SUBSIDIARY FINANCIALS
Gland Pharma International Pte Ltd
Open file
Gland Pharma USA INC
Open file
Manxen SAS
Open file
Manxen 2 SAS
Open file
Manxen 3 SAS
Open file
Phixen SAS
Open file
Cenexi SAS
Open file
Cenexi Services SAS
Open file
Cenexi HSC SAS
Open file
Cenexi 2 SASU
Open file
Cenexi 3 SASU
Open file
Cenexi Laboratories Thissen SA
Open file
Phineximmo SA
Open file
SUBSIDIARY FINANCIALS
Gland Pharma International Pte Ltd
Open file
Gland Pharma USA INC
Open file
SUBSIDIARY FINANCIALS
Gland Pharma International Pte Ltd
Open file
SUBSIDIARY FINANCIALS
Gland Pharma International Pte. Ltd
Open file
